95MO Tinengotinib in patients with advanced, fibroblast growth factor receptor (FGFR) inhibitor refractory/relapsed cholangiocarcinoma
Milind Javle, Lionel Aurelien Kankeu Fonkoua, Amit Mahipal, C-Y. Liao, Christos Fountzilas, D. Li, Meredith S. Pelster, Sanjay Goel, P. Peng, Caixia Sun, Hui Wang, Kristen Hennessy, Xueyao Fu, L. Neo, Y. Shan, Ping Huang, Dong Wu, Frank Wu, Jean Fan, Sarina A. Piha‐Paul
Topics & Concepts
Fibroblast growth factor receptorMedicineRefractory (planetary science)Fibroblast growth factorCancer researchOncologyInternal medicineReceptorAstrobiologyPhysicsCholangiocarcinoma and Gallbladder Cancer StudiesFibroblast Growth Factor ResearchMetastasis and carcinoma case studies